Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Amneal Pharmaceuticals advances DHE autoinjector resubmission and secures FDA approval for exenatide
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX), has achieved two significant milestones, reinforcing its position in the pharmaceutical industry. The company announced the resubmission of its New ... Read More
Revolutionary anti-aging drug sends Telomir Pharma stock soaring—Is the future of longevity here?
Shares of Telomir Pharmaceuticals, Inc. rose significantly in after-hours trading on Wednesday, regaining lost ground following a promising update about its anti-aging drug, Telomir-1. After ... Read More
Why Kura Oncology shares tumbled after securing a $1.2bn cancer-drug partnership
Kura Oncology, Inc., a clinical-stage biopharmaceutical innovator, and Japan-based pharmaceutical leader Kyowa Kirin Co., Ltd., have entered into a strategic partnership that could redefine treatment ... Read More
Quantum-Si collaborates with NVIDIA to redefine proteomics research
Quantum-Si Incorporated, known for its cutting-edge advancements in single-molecule protein sequencing, has announced a pivotal collaboration with NVIDIA. This partnership aims to leverage NVIDIA's accelerated ... Read More
Safecor Health to acquire UDL from Viatris to expand pharmaceutical unit-dose solutions
Safecor Health, a leader in pharmaceutical unit-dose repackaging and supply chain solutions, has announced its acquisition of the U.S. unit-dose packaging business of Viatris Inc., ... Read More
Eyenovia cuts workforce after phase 3 myopia study disappoints
Eyenovia, Inc., an innovator in ophthalmic technologies, has announced a drastic decision to cut 50% of its workforce following the failure of its Phase 3 ... Read More
AstraZeneca to bolster US footprint with multi-billion dollar strategy
In a bold move set to reshape the pharmaceutical landscape, AstraZeneca has announced a substantial $3.5 billion investment aimed at expanding its research and manufacturing ... Read More
Merck licenses innovative anti-cancer therapy LM-299 from LaNova Medicines
In a strategic move to broaden its oncology portfolio, Merck & Co., Inc. (NYSE: MRK), recognized globally as MSD outside the U.S. and Canada, has ... Read More
Biotech breakthrough: Mersana Therapeutics stock soars 23% after blowing past Q3 expectations
Mersana Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) for cancer treatment, saw its shares leap by 23% following a robust ... Read More
Wockhardt sees Q2 revenue surge, driven by antibiotic innovation and biosimilar expansion
Wockhardt Limited, a leading pharmaceutical and biotechnology company, released its second-quarter financial results for the fiscal year 2024-25, showing significant growth across several critical areas. ... Read More